Journal Club
Open Access Article
Drug Shortages and the Burden of Access to Care: A Critical Issue Affecting Patients With Cancer
Pharmaceutical drug shortages are multifaceted and complex problems that affect all aspects of health care, including patients, caregivers, healthcare providers, third-party payers, the pharmaceutical industry, and regulators. Drug shortages have increased significantly since 2000, which cause increases in healthcare costs and compromised patient care. New government regulations have led the U.S. Food and Drug Administration to focus efforts on updating policies and improving regulation of the pharmaceutical industry to limit and avoid drug shortages. This article discusses the current issues surrounding the pharmaceutical drug shortage and the implications for patients and healthcare providers. A review of the literature presents the multidimensional impact of the pharmaceutical drug shortage, and the analysis shows patients who are most burdened by drug shortages and have experienced substandard care, increased cost of care, and compromised quality of health care.
Jump to a section
References
Alspach, J. G. (2012). Is the drug shortage affecting patient care in your critical care unit? Critical Care Nurse, 8, 8-13.
American Society of Clinical Oncology. (2011). 5 suggestions from ASCO to help relieve the oncology drug shortage. Oncology Times, 33(19), 28-29. doi:10.1097/01.COT.0000407163.38543.92
Beeson, J., Lehrfeld, D., Fowler, R., & Manifold, C. (2012). National EMS drug shortage increases. EMS Insider. Retrieved from http://www.jems.com/drugshortages http://www.jems.com/drugshortages
Burr, M. S. (2012). Here today, gone tomorrow: Diagnostic and treatment challenges created by medication shortages and discontinuations. Journal of Pediatric Nursing, 27, 430-432.
Carter, D. (2011). Drug shortage crisis affects patients and nurses. American Journal of Nursing, 111, 14.
Centers for Medicare and Medicaid Services. (2013). Medicare Part B drug average sales price. Retrieved from http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Part-B-Drugs/McrPartBDrugAvgSalesPrice
Chabner, B. A. (2011). Drug shortages—A critical challenge for the generic drug market. New England Journal of Medicine, 365, 2147-2149. doi:10.1056/NEJMp1112633
Costerison, E. C., & Graham, A. S. (2008). Developing and promoting an intranet site for drug a information service. American Journal of Health-System Pharmacy, 65, 639-643. doi:10.2146/ajhp070318
De Oliveira, G. S., Jr., Theilken, L. S., & McCarthy, R. J. (2011). Shortage of perioperative drugs: Implications for anesthesia practice and patient safety. Anesthesia and Analgesia, 113, 1429-1435. doi:10.1213/ANE.0b013e31821f23ef
Dorsey, E. R., Thompson, J. P., Dayoub, E. J., George, B., Saubermann, L. A., & Holloway, R. G. (2009). Selegiline shortage: Causes and costs of a generic drug shortage. Neurology, 73, 213-217. doi:10.1212/WNL.0b013e3181ae7b04
Doyle, J. (2011). Drug ‘shortage’ led supply practice evaluation. EMS Insider. Retrieved from http://www.jems.com/article/ems-insider/drug-shortage-led-supply-pract http://www.jems.com/article/ems-insider/drug-shortage-led-supply-pract
Emanuel, E. J. (2011, August 7). Shortchanging cancer patients. New York Times. Retrieved from http://nyti.ms/18woWSa http://nyti.ms/18woWSa
Exec. Order No. 13,563, 3 C. F. R. 215-217 (2011).
Exec. Order No. 13,588, 3 C. F. R. 281-282 (2011).
Gatesman, M. L., & Smith, T. J. (2011). The shortage of essential chemotherapy drugs in the United States. New England Journal of Medicine, 365, 1653-1655. doi:10.1056/NEJMp1109772
Gehrett, B. K. (2012). A prescription for drug shortages. JAMA, 307, 153-154. doi:10.1001/jama.2011.2000
Golembiewski, J. (2012). Drug shortages in the perioperative setting: Causes, impact, and strategies. Journal of Perianesthesia Nursing, 27, 286-292. doi:10.1016/j.jopan.2012.05.005
Havrilesky, L. J., Garfield, C. F., Barnett, J. C., & Cohn, D. E. (2012). Economic impact of paclitaxel shortage in patients with newly diagnosed ovarian cancer. Gynecologic Oncology, 125, 631-634. doi:10.1016/j.ygyno.2012.03.028
Holcombe, B. (2012). Parenteral nutrition product shortages: Impact on safety. Journal of Parenteral and Enteral Nutrition, 36(Suppl.), 44S-47S. doi:10.1177/0148607111434777
Hunnisett-Dritz, D. (2012). Successful importation of cytarabine into the United States during a critical national drug shortage. American Journal of Health-System Pharmacy, 69, 1416-1421. doi:10.2146/ajhp120113
Jacobson, M., Earle, C. C., Price, M., & Newhouse, J. P. (2010). How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment. Health Affairs, 29, 1391-1399.
Jensen, V., & Rappaport, B. A. (2010). The reality of drug shortages—The case of the injectable agent propofol. New England Journal of Medicine, 363, 806-807. doi:10.1056/NEJMp1005849
Kaakeh, R., Sweet, B. V., Reilly, C., Bush, C., DeLoach, S., Higgins, B., … Stevenson, J. (2011). Impact of drug shortages on U. S. health systems. American Journal of Health-System Pharmacy, 68, 1811-1819. doi:10.2146/ajhp110210
Larkin, H. (2011). Drug shortage may be worst in 30 years. Hospitals and Health Network, 85(2), 28-30.
Link, M. P., Hagerty, K., & Kantarjian, H. M. (2012). Chemotherapy drug shortages in the United States: Genesis and potential solutions. Journal of Clinical Oncology, 30, 692-694.
Mayer, D. K. (2012). Anatomy of a drug shortage. Clinical Journal of Oncology Nursing, 16, 107-108. doi:10.1188/12.CJON.107-108
Stone, A. (2012, January 6). Obama authorizes FDA to address drug shortage. ONS Connect. Retrieved from http://bit.ly/15UpBOs http://bit.ly/15UpBOs
Thompson, C. A. (2009). Drug shortage broaches ethics of buying in excess. American Journal of Health-System Pharmacy, 66, 610-611. doi:10.2146/news090032
U. S. Food and Drug Administration. (2011). A drug supply chain example. Retrieved from http://1.usa.gov/17RMkt6
U. S. Food and Drug Administration. (2013). Current drug shortages index. Retrieved from http://1.usa.gov/cXo7Cl